This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Why Should You Hold Centene (CNC) in Your Portfolio Now?
by Zacks Equity Research
Riding high on strategic initiatives and operational excellence, Centene (CNC) holds potential to reap benefits for investors.
Here's Why You Should Hold Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Riding high on its rising membership, a healthy revenue stream and restructuring measures, Molina Healthcare (MOH) holds potential to reap benefits for investors.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.
Cigna (CI) Expands Its Footprint in the ACA Marketplace
by Zacks Equity Research
Cigna (CI) expands its plan offerings on the Affordable Care Act's insurance exchanges, branching out into additional counties across three states for 2022.
Centene (CNC) Down 8.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Group (UNH) Arm Wins Medicaid Contract in Nevada
by Zacks Equity Research
UnitedHealth Group's (UNH) Nevada unit aims to get better health outcomes of the state's Medicaid beneficiaries via its recent Medicaid program contract win in the counties of Clark and Washoe.
UnitedHealth (UNH) Hits 52-Week High: Hold it for Steady Growth
by Zacks Equity Research
UnitedHealth's (UNH) business diversification, presence in the niche markets and balance sheet strength make it a stock to be retained for long-term gains.
Humana (HUM) Acquires Remaining Shares at Kindred at Home
by Zacks Equity Research
Humana (HUM) closes its Kindred at Home buyout to bolster its home health and hospice business.
Molina (MOH) Arm's Medicaid Contract to Aid Service in Nevada
by Zacks Equity Research
Molina's (MOH) Nevada unit intends to improve the health outcomes of the state's Medicaid members through its recent contract win from the Nevada Department of Health and Human Services - DHCFP.
Centene (CNC) Nevada Unit Gets Contract to Aid Medicaid Members
by Zacks Equity Research
Centene's (CNC) recent contract win aims to enhance health outcomes for Medicaid members of Nevada.
Magellan (MGLN) Unveils Program to Improve Members' Mental Health
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - launched eMbolden program for offering improved behavioral health outcomes for employees and specific clients.
Centene's (CNC) Contract Win to Aid Medicaid Members in Ohio
by Zacks Equity Research
Centene's (CNC) Ohio subsidiary intends to improve health outcomes of the state's Medicaid members through the recent contract win from the Ohio Department of Medicaid.
4 Health Insurance Companies Poised for Growth in 2H21
by Srijita Guha
Strategic initiatives, rising enrolment and strength in Medicaid business are expected to aid health insurance companies like CNC, ANTM, MOH and UNH in 2H21.
Why Centene (CNC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Centene's (CNC) Q2 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings gain from better revenues and membership growth.
Centene (CNC) Misses Q2 Earnings Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -11.35% and 2.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Centene's (CNC) Earnings in Q2?
by Zacks Equity Research
Centene's (CNC) second-quarter results are likely to reflect escalated expenses, partly offset by improved revenues.
Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anthem (ANTM) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Anthem (ANTM) and Humana (HUM) are poised to grow in the thriving insurance brokerage space. Based on certain yardsticks, we try to find out which stock is better than the other.
Centene (CNC) Offers Senior Notes Priced at $1.8 Billion
by Zacks Equity Research
Centene (CNC) exhibits prudence in issuing notes to procure funds for executing the transaction of its Magellan Health acquisition.
Obamacare Upheld in Recent Rulings: A Boon for Healthcare
by Sapna Bagaria
Insurers and hospital companies are now in conducive regulatory environment with the ACA getting a thumbs up from the Supreme Court.
Humana (HUM) Boosts Presence in West Virginia With New Deal
by Zacks Equity Research
Humana (HUM) gets contract renewal from PEIA, which intends to offer better healthcare services to Medicare retirees of West Virginia.
Humana (HUM), League Tie Up for a Digital Health Platform
by Zacks Equity Research
Humana (HUM) teams up with League to launch a digital health and benefits platform for boosting customer experience.
Humana's (HUM) Unit To Enter Atlanta to Serve Aging Population
by Zacks Equity Research
Humana's (HUM) CenterWell unit lay plans to introduce six centers offering high-quality care to local senior patients across Atlanta.
Magellan (MGLN) Unit Generates Cost Savings With Biosimilars
by Zacks Equity Research
Magellan's (MGLN) unit Magellan Rx benefits five health plan members, who utilized its oncology biosimilar solution. This generated annualized savings of more than $40 million for them.